Intensive Care Management of Acute Ischemic Stroke

Emergency Medicine Clinics of North America

Volumn 30, Issue 3, 2012, Pages 713-744

  Burns, Joseph D ^a   Green, Deborah M ^a   Metivier, Kristen ^a   DeFusco, Christina ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute ischemic stroke; Blood pressure control; Cerebral edema; Induced normothermia; Neurocritical care; Pneumonia; Prophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANALGESIC AGENT; ANTICOAGULANT AGENT; BENZODIAZEPINE DERIVATIVE; DEXMEDETOMIDINE; GLUCOSE; HALOPERIDOL; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; INSULIN; LORAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM; MAGNESIUM SULFATE; MANNITOL; MIDAZOLAM; NEUROLEPTIC AGENT; PHENYLEPHRINE; PHENYTOIN; PROPOFOL; PROTON PUMP INHIBITOR; QUETIAPINE; SODIUM CHLORIDE;

AGITATION; ANALGESIA; ANASTOMOSIS; ANTICOAGULATION; ANXIETY; ARTIFICIAL VENTILATION; BEHAVIOR DISORDER; BRAIN DECOMPRESSION; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN PERFUSION; CEREBELLUM INFARCTION; CEREBRAL ARTERY DISEASE; CHEMOPROPHYLAXIS; COMPRESSION GARMENT; CONGESTIVE HEART FAILURE; DECOMPRESSIVE CRANIECTOMY; DEEP VEIN THROMBOSIS; DELIRIUM; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FIBRINOLYTIC THERAPY; FLUID THERAPY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEAD TILTING; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEMODILUTION; HUMAN; HYDROCEPHALUS; HYPERGLYCEMIA; HYPERTENSION; HYPOVOLEMIA; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTRACRANIAL PRESSURE; LOW DRUG DOSE; LUNG DISEASE; LUNG EMBOLISM; NEUROPROTECTION; NONHUMAN; PAIN; PATIENT MONITORING; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; REVIEW; SEDATION; SEIZURE; STRESS ULCER; STUNNED HEART MUSCLE; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 84866149834     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2012.05.002     Document Type: Review

References (146)

1. Saver J.L. Time is brain-quantified. Stroke 2006, 37:263-266.
2. Adams H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke. Stroke 2007, 38:1655-1711.
3. Reeves M.J., Arora S., Broderick J.P. Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell national acute stroke registry. Stroke 2005, 36:1232-1240.
4. Rincon F., Mayer S.A., Rivolta J. Impact of delayed transfer of critically ill stroke patients from the emergency department to the neuro-ICU. Neurocrit Care 2010, 13:75-81.
5. Nguyen T., Koroshetz W.J. Intensive care management of ischemic stroke. Curr Neurol Neurosci Rep 2003, 3:32-39.
6. Wartenberg K.E., Schmidt M., Mayer S.A. Multimodality monitoring in neurocritical care. Crit Care Clin 2007, 23:507-538.
7. Hillered L., Vespa P.M., Hovda D.A. Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis. J Neurotrauma 2005, 22:3-41.
8. Kasner S.E. Clinical interpretation and use of stroke scales. Lancet Neurol 2006, 5:603-612.
9. Wijdicks E.F., Bamlet W.R., Maramattom B.V., et al. Validation of a new coma scale: the FOUR score. Ann Neurol 2005, 58:585-593.
10. Idrovo L., Fuentes B., Medina J., et al. Validation of the FOUR score (Spanish version) in acute stroke: an interobserver variability study. Eur Neurol 2010, 63:364-369.
11. Kornbluth J., Bhardwaj A. Evaluation of coma: a critical appraisal of popular scoring systems. Neurocrit Care 2011, 14:134-143.
12. Stead L.G., Wijdicks E.F., Bhagra A., et al. Validation of a new coma scale, the FOUR score, in the emergency department. Neurocrit Care 2009, 10:50-54.
13. Rose J.C., Mayer S.A. Optimizing blood pressure in neurological emergencies. Neurocrit Care 2004, 3:287-300.
14. Qureshi A.I. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008, 118:176-187.
15. Sandset E.C., Bath P.M., Boysen G., et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011, 377:741-750.
16. Mayer S.A., Kurtz P., Wyman A., et al. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the studying the treatment of acute hypertension (STAT) registry. Crit Care Med 2011, 39:2330-2336.
17. Oliveira-Fihlo J., Silva S.C., Trabuco C.C., et al. Detrimental effects of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 2003, 61:1047-1051.
18. van Mook W.N., Rennenberg R.J., Schurink G.W., et al. Cerebral hyperperfusion syndrome. Lancet Neurol 2005, 4:877-878.
19. Barer D.H., Cruickshank J.M., Ebrahim S.B., et al. Low dose beta blockade in acute stroke (" BEST" trial): an evaluation. BMJ 1988, 296:737-741.
20. Mistri A.K., Robinson T.G., Potter J.F. Pressor therapy in acute ischemic stroke: a systematic review. Stroke 2006, 37:1565-1571.
21. Rodriguez G.J., Cordina S.M., Vazquez G., et al. The hydration influence on risk of stroke (THIRST) study. Neurocrit Care 2009, 10:187-194.
22. Bhalla A., Sankaralingam S., Dundas R., et al. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke 2000, 31:2043-2048.
23. Aicher F.T., Fazekas F., Brainin M., et al. Hypervolemic hemodilution in acute ischemic stroke: the multicenter Austrian hemodilution stroke trial (MAHST). Stroke 1998, 29:743-749.
24. Wojner-Alexander A.W., Garani Z., Chenyshev O.Y., et al. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 2005, 64:1354-1357.
25. Schwarz S., Georgiadis D., Aschoff A., et al. Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 2002, 33:497-501.
26. Drakulovic M.B., Torres A., Bauer T.T., et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999, 354:1851-1858.
27. Wijdicks E.F. "Comatose". The practice of emergency and critical care neurology 2010, Oxford University Press, Oxford (United Kingdom).
28. Hornig C.R., Rust D.S., Busse O., et al. Space-occupying cerebellar infarction. Clinical course and prognosis. Strok 1994, 25:372-374.
29. Hacke W., Schwab S., Horn M. "Malignant" middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996, 53:309-315.
30. Manno E.M., Nichols D.R., Fulgham J.R., et al. Computed tomographic determinants of neurologic deterioration in patients with large middle cerebral artery infarctions. Mayo Clin Proc 2003, 78:156-160.
31. Frank J.I. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995, 45:1286-1290.
32. Huttner H.B., Schwab S. Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives. Lancet Neurol 2009, 8:949-958.
33. Moulin T., Cattin F., Crepin-Leblond T., et al. Early CT signs in acute middle cerebral artery infarction: predictive value for subsequent infarct locations and outcome. Neurology 1996, 47:366-375.
34. Wijdicks E.F., Diringer M.N. Middle cerebral artery territory infarction and early brain swelling: progression and effect of age on outcome. Mayo Clin Proc 1998, 73:829-836.
35. Hofmeijer J., Kappelle L.J., Algra A., et al. Surgical decompression for space-occupying cerebral infarction (the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 2009, 8:326-333.
36. Wijdicks E.F. Intracranial pressure. The practice of emergency and critical care neurology 2010, Oxford University Press, Oxford (United Kingdom).
37. Koenig M.A., Bryan M., Lewin J.L., et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008, 70:1023-1029.
38. Kamal H., Navi B.B., Nakagawa K., et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011, 39:554-559.
39. Juttler E., Schwab S., Schmiedek P., et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke 2007, 38:2518-2525.
40. Vahedi K., Vicaut E., Mateo J., et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke 2007, 38:2506-2517.
41. Koh M.G., Phan T.G., Atkinson J.L., et al. Neuroimaging in deteriorating patients with cerebellar infarcts and mass effect. Stroke 2000, 31:2062-2067.
42. Kase C.S., Norrving B., Levine S.R., et al. Cerebellar infarction. Clinical and anatomic observation in 66 cases. Stroke 1993, 24:76-83.
43. Amarenco P. The spectrum of cerebellar infarctions. Neurology 1991, 41:973-979.
44. Macdonnell R.A., Kalnins R.N., Donnan G.A. Cerebellar infarction: natural history, prognosis, and pathology. Stroke 1987, 18:849-855.
45. Jauss M., Krieger D., Hornig C., et al. Surgical and medical management of patients with massive cerebellar infarctions: results of the German-Austrian cerebellar infarction study. J Neurol 1997, 246:257-264.
46. Heros R.C. Cerebellar hemorrhage and infarction. Stroke 1982, 13:106-109.
47. Juttler E., Schweikert S., Ringleb P.A., et al. Long-term outcome after surgical treatment for space-occupying cerebellar infarction: experience in 56 patients. Stroke 2009, 40:3060-3066.
48. Pfefferkorn T., Eppinger U., Linn J., et al. Long-term outcome after suboccipital decompressive craniectomy for malignant cerebellar infarction. Stroke 2009, 40:3045-3050.
49. Wijdicks E.F. Cerebellar infarct. The practice of emergency and critical care neurology 2010, Oxford University Press, Oxford (United Kingdom).
50. The National Institute for Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-1587.
51. Sussman B.J., Fitch T.S. Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 1958, 167:1705-1709.
52. Meyer J.S., Gilroy J., Barnhart M.I., et al. Therapeutic thrombolysis in cerebral thromboembolism: double-blind evaluation of intravenous plasmin therapy in carotid and middle cerebral arterial occlusion. Neurology 1963, 13:927-937.
53. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 2000, 283:1151-1158.
54. Engleter S.T., Fluri F., Buitrago-Tellez C., et al. Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 2005, 252:1167-1170.
55. Hill M.D., Lye T., Moss H., et al. Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003, 60:1525-1527.
56. Hill M.D., Barber P.A., Takahashi J. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000, 162:1281-1284.
57. Sandercock P.A., Counsell C., Kamal A.K. Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev 2008, (8). CD000024.
58. Albers G.W., Amaerenco P., Easton J.D., et al. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008, 133:630S-669S.
59. Schonewille W.J., Algra A., Serena J., et al. Outcome in patients treated with basilar artery occlusion conventionally. J Neurol Neurosurg Psychiatry 2005, 76:1238-1241.
60. Schonewille W.J., Wijman C.A., Michel P., et al. Treatment and outcomes in acute basilar artery occlusion in the basilar artery international cooperation study (BASICS): a prospective registry study. Lancet Neurol 2009, 8:724-730.
61. Mattle H.P., Arnold M., Lindsberg P.J., et al. Basilar artery occlusion. Lancet Neurol 2011, 10:1002-1014.
62. Engleter S.T., Brandt T., Debette S., et al. Antiplatelets versus anticoagulation in cervical artery dissection. Stroke 2007, 38:2605-2611.
63. Nehler M.R., Moneta G.L., McConnell D.B., et al. Anticoagulation followed by elective carotid surgery in patients with repetitive transient ischemic attacks and high-grade carotid stenosis. Arch Surg 1993, 128:1117-1121.
64. Adams H.P., Bendixen B.H., Leira E., et al. Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999, 53:122-125.
65. Yasaka M., Yamaguchi T. Immediate anticoagulation for intracardiac thrombus in acute cardioembolic stroke. Angiology 1992, 43:886-892.
66. Yasaka M., Yamaguchi T., Miyashita T., et al. Regression of intracardiac thrombus after embolic stroke. Stroke 1990, 21:1540-1544.
67. Chamorro A., Vila A., Saiz A., et al. Early anticoagulation after large cerebral embolic infarction: a safety study. Neurology 1995, 45:861-865.
68. Babikian V.L., Kase C.S., Pessin M.S., et al. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 1989, 20:1500-1503.
69. Camilo O., Goldstein L.B. Seizures and epilepsy after ischemic stroke. Stroke 2004, 35:1769-1775.
70. Goldstein L.B. Potential effects of common drugs on stroke recovery. Arch Neurol 1998, 55:454-456.
71. Goldstein L.B. Common drugs may influence motor recovery after stroke. Neurology 1995, 45:865-871.
72. Belcastro V., Pierquidi L., Tambasco N. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy. Brain Dev 2011, 33:289-293.
73. Devlin J.W., Roberts R.J., Fong J.J., et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010, 38:419-427.
74. Wan R.Y., Kasliwal M., McKenzie C.A., et al. Quetiapine in refractory hyperactive and mixed intensive care delirium: a case series. Crit Care 2011, 15:R159.
75. Teitelbaum J.S., Ayoub O., Skrobik Y. A critical appraisal of sedation, analgesia, and delirium in neurocritical care. Can J Neurol Sci 2011, 38:815-825.
76. Wijdicks E.F. Agitation and pain. The practice of emergency and critical care neurology 2010, Oxford University Press, Oxford (United Kingdom).
77. Riker R.R., Fraser G.L. Altering intensive care sedation paradigms to improve patient outcomes. Crit Care Clin 2009, 25:527-538.
78. Aryan H.E., Box K.W., Ibrahim D., et al. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj 2006, 20:791-798.
79. Mirski M.A., Lewin J.J., Ledroux S., et al. Cognitive improvement during continuous sedation in critically ill awake and responsive patients: the acute neurological ICU sedation trial (ANIST). Intensive Care Med 2010, 36:1505-1513.
80. Grof T.M., Bledsoe K.A. Evaluating the use of dexmedetomidine in neurocritical care patients. Neurocrit Care 2010, 12:356-361.
81. Silver F.L., Norris J.W., Lewis A.J., et al. Early mortality following stroke: A prospective review. Stroke 1984, 15:492-496.
82. Bamford J., Dennis M., Sandercock P., et al. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatry 1990, 53:824-829.
83. Love B.B., Biller J., Wilber D.J. Cardiac manifestations of neurological disorders. The interface of neurology & internal medicine 2008, 1-7. Wolters Kluwer/Lippincott Williams & Wilkins, Philadephia. J. Biller (Ed.).
84. Angelantonio E.D., Fiorelli M., Toni D., et al. Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2005, 76:76-81.
85. Scheitz J.F., Mochmann H.C., Nolte C.H., et al. Troponin elevation in acute ischemic stroke (TRELAS) - protocol of a prospective observational trial. BMC Neurol 2011, 11:98.
86. Rost N.S., Biffi A., Cloonan L., et al. Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke 2012, 43(2):441-445.
87. Tu H.T., Campbell B.C., Churilov L., et al. Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis 2011, 32:454-460.
88. Micheli S., Agnelli G., Caso V. Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome. J Neurol 2012, 259:106-110.
89. Samuels M.A. The brain-heart connection. Circulation 2007, 116:77-84.
90. Prasad A., Lerman A., Rihal C.S. Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008, 155:408-417.
91. Nguyen H., Zaroff J.G. Neurogenic stunned myocardium. Curr Neurol Neurosci Rep 2009, 9:486-491.
92. Gujjar A.R., Deibert E., Manno E.M., et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 1998, 51:447-451.
93. Grotta J., Pasteur W., Khwaja G., et al. Elective intubation for neurologic deterioration after stroke. Neurology 1995, 45:640-644.
94. Berrouschot J., Rossler A., Koster J., et al. Mechanical ventilation in patients with hemispheric ischemic stroke. Crit Care Med 2000, 28:2956-2961.
95. Milhaud D., Popp J., Thouvenot E., et al. Mechanical ventilation in ischemic stroke. J Stroke Cerebrovasc Dis 2004, 13:183-188.
96. Wijdicks E.F., Borel C.O. Respiratory management in acute neurologic illness. Neurology 1998, 50:11-20.
97. Wijdicks E.F., Scott J.P. Outcome in patients with acute basilar artery occlusion requiring mechanical ventilation. Stroke 1996, 27:1301-1303.
98. Ropper A.H., Gress D.R., Diringer M.N., et al. Critical care of Guillain-Barre syndrome. Neurological and neurosurgical intensive care 2004, Lippincott, Williams & Wilkins, Philadephia. 4th edition.
99. Nava S., Hill N. Non-invasive ventilation in acute respiratory failure. Lancet 2009, 374:250-259.
100. Kuzac N., Harrison D.W., Zed P.J. Use of lidocaine and fentanyl premedication for neuroprotective rapid sequence intubation in the emergency department. CJEM 2006, 8:80-84.
101. Clancy M., Halford S., Walls R., et al. In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review. Emerg Med J 2001, 18:373-375.
102. Albanese J., Viviand X., Potie F., et al. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med 1999, 27:407-411.
103. Zed P.J., Abu-Laban R.B., Harrison D.W. Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med 2006, 13:378-383.
104. Filanovsky Y., Miller P., Kao J. Myth: ketamine should not be used as an induction agent for intubation in patients with head injury. CJEM 2010, 12:154-157.
105. Michalski D., Hartig W., Schneider D., et al. Use of normobaric and hyperbaric oxygen in acute focal cerebral ischemia-a preclinical and clinical review. Acta Neurol Scand 2011, 123:85-97.
106. Marik P.E., Baram M., Vahid B. Does central venous pressure predict fluid responsiveness: a systematic review of the literature and the tale of seven mares. Chest 2008, 134:172-178.
107. Haidan M., Pinsky M.R. Evidence-based review of the use of the pulmonary artery catheter: impact data and complications. Crit Care 2006, 10(Suppl 3):S8.
108. Simma B., Burger R., Falk M. A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated ringer's solution versus hypertonic saline. Crit Care Med 1998, 26:1265-1270.
109. Ramming S., Schackford S.R., Zhuang J., et al. The relationship of fluid balance and sodium administration to cerebral edema formation and intracranial pressure in a porcine model of brain injury. J Trauma 1994, 37:705-713.
110. Ziai W.C., Tuong T.J., Bhardwaj A. Hypertonic saline: first-line therapy for cerebral edema?. J Neurol Sci 2007, 261:157-166.
111. Bhardwaj A., Harkuni I., Murphy S.J., et al. Hypertonic saline worsens infarct volume after transient cerebral ischemia in rats. Stroke 2000, 31:1694-1701.
112. Ginsberg M.D., Palesch Y.Y., Martin R.H., et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke 2011, 42:119-127.
113. Sahota P., Savitz S.I. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery. Neurotherapeutics 2011, 8:434-451.
114. Goyal A., Spertus J.A., Gosch K., et al. Serum potassium levels and mortality in acute myocardial infarction. JAMA 2012, 307:157-164.
115. Green D.M., Ropper A.H., Kronmal R.A., et al. Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology 2002, 59:314-320.
116. Rabinstein A.A., Wijdicks E.F. Hyponatremia in critically ill neurologic patients. Neurologist 2003, 9:290-300.
117. Polderman K.H. Induced hypothermia and fever control for prevention and treatment of neurological injuries. Lancet 2008, 371:1955-1969.
118. Badjatia N. Hyperthermia and fever control in brain injury. Crit Care Med 2009, 37(Suppl 7):S250-S257.
119. Reith J., Jorgensen H.S., Pedersen P.M., et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996, 347:422-425.
120. Puccio A.M., Fischer M.R., Jankowitz B.T., et al. Induced normothermia attenuates intracranial hypertension and reduces fever burden after severe traumatic brain injury. Neurocrit Care 2009, 11:82-87.
121. Oddo M., Frangos S., Milby A., et al. Induced normothermia attenuates cerebral metabolic distress in patients with aneurysmal subarachnoid hemorrhage and refractory fever. Stroke 2009, 40:1913-1916.
122. Sessler D.I. Thermoregulatory defense mechanisms. Crit Care Med 2009, 37(Suppl 7):S203-S210.
123. Oddo M. Effect of shivering on brain tissue oxygenation during induced normothermia in patients with severe brain injury. Neurocrit Care 2010, 12:10-16.
124. Choi H.A., Ko S.B., Presciutti M., et al. Prevention of shivering during therapeutic temperature modulation: the Columbia anti-shivering protocol. Neurocrit Care 2011, 14:389-394.
125. Linares G., Mayer S.A. Hypothermia for the treatment of ischemic and hemorrhagic stroke. Crit Care Med 2009, 37(Suppl 7):S243-S249.
126. Hemmen T.M., Raman R., Guluma K.Z., et al. Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke (ICTuS-L): final results. Stroke 2010, 41:2265-2270.
127. Schwab S., Georgiadis D., Berrouschot J., et al. Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 2001, 32:2033-2035.
128. De Georgia M.A., Krieger D.W., Abou-Chebl A., et al. Cooling of acute ischemic brain damage (COOL-AID): a feasibility trial of endovascular cooling. Neurology 2004, 63:312-317.
129. Steiner T., Freide T., Aschoff A., et al. Effect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery. Stroke 2001, 32:2833-2835.
130. Kase C.S., Furlan A.J., Wechsler L.R., et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001, 57:1603-1610.
131. Demchuck A.M., Morganstern L.B., Krieger D.W., et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 1999, 30:34-39.
132. Lindsberg P.J., Roine R.O. Hyperglycemia in acute stroke. Stroke 2004, 35:363-364.
133. Candelise L., Landi G., Orazio E.N., et al. Prognostic significance of hyperglycemia in acute stroke. Arch Neurol 1985, 42:661-663.
134. Baird T.A., Parsons M.W., Phanh T., et al. Persistent post-stroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome. Stroke 2003, 34:2208-2214.
135. NICE-SUGAR Investigators Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360:1283-1297.
136. Green D.M., O'Phelan K.H., Bassin S.L., et al. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocrit Care 2010, 13:299-306.
137. Oddo M., Schmidt J.M., Carrera E., et al. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 2008, 36:3233-3238.
138. Hinchey J.A., Shephard T., Furie K., et al. Formal dysphagia screening protocols prevent pneumonia. Stroke 2005, 36:1972-1976.
139. Martino R., Foley N., Bhogal S., et al. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005, 36:2756-2763.
140. DePippo K.L., Holas M.A., Reding M.J. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol 1992, 49:1259-1261.
141. Kelly J., Rudd A., Lewis R.R., et al. Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging. Stroke 2004, 35:2320-2325.
142. Raslan A.M., Fields J.D., Bhardwaj A. Prophylaxis for venous thrombo-embolism in neurocritical care: a critical appraisal. Neurocrit Care 2010, 12:297-309.
143. Mazzone C., Chiodo G.F., Sandercock P., et al. Physical methods for preventing deep venous thrombosis in stroke. Cochrane Database Syst Rev 2004, (4). CD0001922.
144. Schirmer C.M., Kornbluth J., Heilman C.B., et al. Gastrointestinal prophylaxis in neurocritical care. Neurocrit Care 2012, 16(1):184-193.
145. Rabinstein A.A., Hemphill J.C. Prognosticating after severe, acute brain disease: science, art, and biases. Neurology 2010, 74:1086-1087.
146. Becker K.J., Baxter A.B., Cohen W.A., et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 2001, 56:766-772.